CT during arterial portography (CTAP) is based on portal enhancement o
f the liver by infusion of contrast material through the superior mese
nteric or splenic artery. This technique provides high degrees of enha
ncement of the portal vein and intrahepatic vessels, allowing reliable
segmental localisation of tumours and accurate assessment of relation
ships between tumours and intrahepatic vessels. Because of its invasiv
eness, CTAP must be limited to patients for whom non-invasive preopera
tive imaging suggests resectable tumour. In the majority of cases, CTA
P is performed in patients with hepatic metastases from colorectal can
cer, but other types of hepatic tumour (either primary or secondary) a
nd pancreatic tumour may be an indication for CTAP. Visualisation of n
on-tumorous perfusion defects is a limitation of this technique, but s
uch defects have been well described and have characteristic locations
and appearance. In difficult cases, correlation with sonographic, CT
and MRI findings helps characterise portal perfusion defects. CTAP is
the most sensitive technique for the detection of intrahepatic tumours
, and the recent use of spiral technology shows promise in the perform
ance of CTAP. CTAP data can be viewed as multiplanar and three-dimensi
onal reconstructions that allow preoperative planning of the extent of
resection and determination of the volume of the remaining liver afte
r resection.